TWINRIX

This brand name is authorized in Austria, Brazil, Canada, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Italy, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, United Kingdom, United States, South Africa

Active ingredients

The drug TWINRIX contains a combination of these active pharmaceutical ingredients (APIs):

1 Hepatitis A virus antigen (HM-175 strain) UNII 5BFC8LZ6LQ - HEPATITIS A VIRUS STRAIN HM175 ANTIGEN (FORMALDEHYDE INACTIVATED)

Inactivated virus of a strain which was originally derived by further serial passage of a proven attenuated strain. The virus is grown, harvested, highly purified, formalin inactivated, and then adsorbed onto amorphous aluminum hydroxyphosphate sulphate. Read about Hepatitis A, inactivated vaccine

2 Hepatitis B surface antigen (HBS AG) recombinant UNII 9GCJ1L5D1P - HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN

Hepatitis B vaccine induces specific humoral antibodies against hepatitis B virus surface antigen (anti-HBsAg). Hepatitis B vaccine has been recognized as the first anti-cancer vaccine because it can prevent primary liver cancer. Read about Hepatitis B, purified antigen

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J07BC20	Combinations	J Antiinfectives for systemic use → J07 Vaccines → J07B Viral vaccines → J07BC Hepatitis vaccines
Discover more medicines within J07BC20

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 510608202151316
Country: CA	Health Products and Food Branch	Identifier(s): 02230578, 02237548
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 22.633-1-12-05
Country: EE	Ravimiamet	Identifier(s): 1039328, 1039339, 1215302, 1215313, 1215436, 1215447, 1215458, 1215469, 1215481, 1215492, 1215504, 1215515
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 96020007, 97029006
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 143511, 144022, 170092, 170142
Country: FR	Base de données publique des médicaments	Identifier(s): 65991659
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 29948, 29962, 29978
Country: HK	Department of Health Drug Office	Identifier(s): 43814
Country: IT	Agenzia del Farmaco	Identifier(s): 033014010, 033014022, 033014034, 033014046, 033014059, 033014061, 033014073, 033014085, 033014097, 033014109, 033014111, 033014123, 033014135, 033014147, 033014150, 033014162, 033014174, 033014186, 033014198
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1008868, 1031465, 1031466, 1031470, 1031471, 1031472, 1031473, 1031474, 1031478, 1031479, 1031480, 1031481, 1031482
Country: NL	Z-Index G-Standaard	Identifier(s): 14940035
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 48933
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 7859, 7860
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100000296, 100127335
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W52725001, W52725002, W52725003, W52725004, W52725005, W52725006
Country: SG	Health Sciences Authority	Identifier(s): 10932P
Country: US	FDA, National Drug Code	Identifier(s): 50090-1645, 58160-815
Country: ZA	Health Products Regulatory Authority	Identifier(s): 32/30.1/0244